デフォルト表紙
市場調査レポート
商品コード
1139971

消化酵素市場:起源別、酵素タイプ別、用途別:世界の機会分析および産業予測、2021-2031年

Digestive Enzymes Market By Origin, By Enzyme Type, By Applications : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 178 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
消化酵素市場:起源別、酵素タイプ別、用途別:世界の機会分析および産業予測、2021-2031年
出版日: 2022年07月01日
発行: Allied Market Research
ページ情報: 英文 178 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

消化酵素市場は2021年に6億9940万米ドル、2031年には16億4360万米ドルに達すると予測され、2022年から2031年にかけてCAGRは8.7%で成長すると予測しています。

消化酵素はタンパク質、炭水化物、脂質を分解し、その補給は乳糖不耐症から嚢胞性線維症まで、消化器系疾患の管理に役割を果たします。消化酵素は、酵素の種類、原料や由来、摂取量などの点で互いに異なるいくつかの製剤が市場に出回っています。動物由来の酵素は、標準的な治療法として確立されています。しかし、植物由来や微生物由来の酵素の研究が進み、消化酵素療法は大きく進歩しています。さらに、膵酵素の補給は、慢性膵炎、膵臓癌、嚢胞性線維症(CF)、または糖尿病における外分泌膵機能不全(EPI)の管理のために選択される治療法です。1日に必要な酵素の量は、年齢や体重、嚢胞性線維症では遺伝子型や腸内因子が吸収に影響するなど、患者の病因や臨床症状の重症度に関連するため、変動があります。

消化器系問題の有病率の増加、人口による不健康なライフスタイルの増加、老人人口の増加などの消化酵素市場の動向は、消化酵素市場の成長を促進する主な要因です。また、フィットネスセンターやスポーツジムの急増は、栄養補助食品の需要を増加させ、GIヘルスに関する意識の高まり、予防的疾病管理の焦点は、市場の成長に向けて貢献する他の要因です。しかし、適切な投与量に関する知識の不足や、消化酵素サプリメントの代替品の存在が、市場の成長を妨げると予想されます。逆に、カスタマイズされた消化酵素の開発は、市場成長のための有利な機会を提供します。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 消化酵素市場:オリジン別

  • 概要
    • 市場規模および予測
  • 動物
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 微生物分野
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 植物
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 消化酵素市場:酵素の種類別

  • 概要
    • 市場規模および予測
  • カーボハイドラーゼ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • プロテアーゼ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • リパーゼ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • その他の酵素タイプ
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 消化酵素市場:用途別

  • 概要
    • 市場規模および予測
  • 処方薬
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • スポーツニュートリション
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 乳児用栄養剤
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第7章 消化酵素市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米市場規模・予測:原産地別
    • 北米市場規模・予測:酵素タイプ別
    • 北米市場規模・予測:用途別
    • 北米市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州市場規模・予測:原産地別
    • 欧州市場規模・予測:酵素タイプ別
    • 欧州市場規模・予測:アプリケーション別
    • 欧州市場規模・予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他の欧州地域
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:原産地別
    • アジア太平洋地域の市場規模・予測:酵素タイプ別
    • アジア太平洋地域の市場規模・予測:用途別
    • アジア太平洋地域の市場規模・予測:国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:原産地別
    • LAMEAの市場規模・予測:酵素タイプ別
    • LAMEAの市場規模・予測:アプリケーション別
    • LAMEAの市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ共和国
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • Allergan PLC
  • Abbvie Inc.
  • Amway Corporation
  • Country Life LLC.
  • Garden Of Life Inc.
  • Biotics Research Corporation
  • Metagenics, Inc.
  • Abbott Nutrition.
  • Johnson & Johnson
  • Archer Daniels Midland Company(DeerLand Enzymes)
図表

LIST OF TABLES

  • TABLE 1. GLOBAL DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 2. DIGESTIVE ENZYMES MARKET SIZE, FOR ANIMAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. DIGESTIVE ENZYMES MARKET FOR ANIMAL BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. DIGESTIVE ENZYMES MARKET SIZE, FOR MICROBIAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. DIGESTIVE ENZYMES MARKET FOR MICROBIAL BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. DIGESTIVE ENZYMES MARKET SIZE, FOR PLANT, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. DIGESTIVE ENZYMES MARKET FOR PLANT BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 9. DIGESTIVE ENZYMES MARKET SIZE, FOR CARBOHYDRASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. DIGESTIVE ENZYMES MARKET FOR CARBOHYDRASE BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. DIGESTIVE ENZYMES MARKET SIZE, FOR PROTEASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. DIGESTIVE ENZYMES MARKET FOR PROTEASE BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. DIGESTIVE ENZYMES MARKET SIZE, FOR LIPASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. DIGESTIVE ENZYMES MARKET FOR LIPASE BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. DIGESTIVE ENZYMES MARKET SIZE, FOR OTHER ENZYME TYPES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. DIGESTIVE ENZYMES MARKET FOR OTHER ENZYME TYPES BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 18. DIGESTIVE ENZYMES MARKET SIZE, FOR PRESCRIPTION MEDICINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. DIGESTIVE ENZYMES MARKET FOR PRESCRIPTION MEDICINE BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. DIGESTIVE ENZYMES MARKET SIZE, FOR SPORTS NUTRITION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. DIGESTIVE ENZYMES MARKET FOR SPORTS NUTRITION BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. DIGESTIVE ENZYMES MARKET SIZE, FOR INFANT NUTRITION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 23. DIGESTIVE ENZYMES MARKET FOR INFANT NUTRITION BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 24. DIGESTIVE ENZYMES MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA DIGESTIVE ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. U.S. DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 30. U.S. DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 31. U.S. DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 32. CANADA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 33. CANADA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 34. CANADA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 36. MEXICO DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE DIGESTIVE ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 42. GERMANY DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 43. GERMANY DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 44. GERMANY DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 45. FRANCE DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 46. FRANCE DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 47. FRANCE DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 48. U.K. DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 49. U.K. DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 50. U.K. DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 51. ITALY DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 52. ITALY DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 53. ITALY DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 54. SPAIN DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 55. SPAIN DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 56. SPAIN DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 57. REST OF EUROPE DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 58. REST OF EUROPE DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 59. REST OF EUROPE DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 60. ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 61. ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 62. ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 64. JAPAN DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 65. JAPAN DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 66. JAPAN DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 67. CHINA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 68. CHINA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 69. CHINA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 70. INDIA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 71. INDIA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 72. INDIA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 73. AUSTRALIA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 74. AUSTRALIA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 75. AUSTRALIA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 76. SOUTH KOREA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 77. SOUTH KOREA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 78. SOUTH KOREA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 79. REST OF ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 80. REST OF ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 81. REST OF ASIA-PACIFIC DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 82. LAMEA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 84. LAMEA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 85. LAMEA DIGESTIVE ENZYMES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 86. BRAZIL DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 87. BRAZIL DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 88. BRAZIL DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 89. SAUDI ARABIA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 90. SAUDI ARABIA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 91. SAUDI ARABIA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH AFRICA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 93. SOUTH AFRICA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 94. SOUTH AFRICA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 95. REST OF LAMEA DIGESTIVE ENZYMES MARKET, BY ORIGIN, 2021-2031 ($MILLION)
  • TABLE 96. REST OF LAMEA DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE, 2021-2031 ($MILLION)
  • TABLE 97. REST OF LAMEA DIGESTIVE ENZYMES MARKET, BY APPLICATIONS, 2021-2031 ($MILLION)
  • TABLE 98.ALLERGAN PLC: COMPANY SNAPSHOT
  • TABLE 99.ALLERGAN PLC: OPERATING SEGMENTS
  • TABLE 100.ALLERGAN PLC: PRODUCT PORTFOLIO
  • TABLE 101.ALLERGAN PLC: NET SALES,
  • TABLE 102.ALLERGAN PLC: KEY STRATERGIES
  • TABLE 103.ABBVIE INC.: COMPANY SNAPSHOT
  • TABLE 104.ABBVIE INC.: OPERATING SEGMENTS
  • TABLE 105.ABBVIE INC.: PRODUCT PORTFOLIO
  • TABLE 106.ABBVIE INC.: NET SALES,
  • TABLE 107.ABBVIE INC.: KEY STRATERGIES
  • TABLE 108.AMWAY CORPORATION: COMPANY SNAPSHOT
  • TABLE 109.AMWAY CORPORATION: OPERATING SEGMENTS
  • TABLE 110.AMWAY CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111.AMWAY CORPORATION: NET SALES,
  • TABLE 112.AMWAY CORPORATION: KEY STRATERGIES
  • TABLE 113.COUNTRY LIFE LLC.: COMPANY SNAPSHOT
  • TABLE 114.COUNTRY LIFE LLC.: OPERATING SEGMENTS
  • TABLE 115.COUNTRY LIFE LLC.: PRODUCT PORTFOLIO
  • TABLE 116.COUNTRY LIFE LLC.: NET SALES,
  • TABLE 117.COUNTRY LIFE LLC.: KEY STRATERGIES
  • TABLE 118.GARDEN OF LIFE INC.: COMPANY SNAPSHOT
  • TABLE 119.GARDEN OF LIFE INC.: OPERATING SEGMENTS
  • TABLE 120.GARDEN OF LIFE INC.: PRODUCT PORTFOLIO
  • TABLE 121.GARDEN OF LIFE INC.: NET SALES,
  • TABLE 122.GARDEN OF LIFE INC.: KEY STRATERGIES
  • TABLE 123.BIOTICS RESEARCH CORPORATION: COMPANY SNAPSHOT
  • TABLE 124.BIOTICS RESEARCH CORPORATION: OPERATING SEGMENTS
  • TABLE 125.BIOTICS RESEARCH CORPORATION: PRODUCT PORTFOLIO
  • TABLE 126.BIOTICS RESEARCH CORPORATION: NET SALES,
  • TABLE 127.BIOTICS RESEARCH CORPORATION: KEY STRATERGIES
  • TABLE 128.METAGENICS, INC.: COMPANY SNAPSHOT
  • TABLE 129.METAGENICS, INC.: OPERATING SEGMENTS
  • TABLE 130.METAGENICS, INC.: PRODUCT PORTFOLIO
  • TABLE 131.METAGENICS, INC.: NET SALES,
  • TABLE 132.METAGENICS, INC.: KEY STRATERGIES
  • TABLE 133.ABBOTT NUTRITION.: COMPANY SNAPSHOT
  • TABLE 134.ABBOTT NUTRITION.: OPERATING SEGMENTS
  • TABLE 135.ABBOTT NUTRITION.: PRODUCT PORTFOLIO
  • TABLE 136.ABBOTT NUTRITION.: NET SALES,
  • TABLE 137.ABBOTT NUTRITION.: KEY STRATERGIES
  • TABLE 138.JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 139.JOHNSON & JOHNSON: OPERATING SEGMENTS
  • TABLE 140.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
  • TABLE 141.JOHNSON & JOHNSON: NET SALES,
  • TABLE 142.JOHNSON & JOHNSON: KEY STRATERGIES
  • TABLE 143.ARCHER DANIELS MIDLAND COMPANY (DEERLAND ENZYMES): COMPANY SNAPSHOT
  • TABLE 144.ARCHER DANIELS MIDLAND COMPANY (DEERLAND ENZYMES): OPERATING SEGMENTS
  • TABLE 145.ARCHER DANIELS MIDLAND COMPANY (DEERLAND ENZYMES): PRODUCT PORTFOLIO
  • TABLE 146.ARCHER DANIELS MIDLAND COMPANY (DEERLAND ENZYMES): NET SALES,
  • TABLE 147.ARCHER DANIELS MIDLAND COMPANY (DEERLAND ENZYMES): KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.DIGESTIVE ENZYMES MARKET SEGMENTATION
  • FIGURE 2.DIGESTIVE ENZYMES MARKET,2021-2031
  • FIGURE 3.DIGESTIVE ENZYMES MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.DIGESTIVE ENZYMES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.DIGESTIVE ENZYMES MARKET,BY ORIGIN,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANIMAL DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF MICROBIAL DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PLANT DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 16.DIGESTIVE ENZYMES MARKET,BY ENZYME TYPE,2021(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CARBOHYDRASE DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PROTEASE DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF LIPASE DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHER ENZYME TYPES DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 21.DIGESTIVE ENZYMES MARKET,BY APPLICATIONS,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PRESCRIPTION MEDICINE DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SPORTS NUTRITION DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF INFANT NUTRITION DIGESTIVE ENZYMES MARKET,2021-2031(%)
  • FIGURE 25.DIGESTIVE ENZYMES MARKET BY REGION,2021
  • FIGURE 26.U.S. DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 27.CANADA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 28.MEXICO DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 29.GERMANY DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 30.FRANCE DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 31.U.K. DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 32.ITALY DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 33.SPAIN DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 34.REST OF EUROPE DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 35.JAPAN DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 36.CHINA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 37.INDIA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH KOREA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF ASIA-PACIFIC DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 41.BRAZIL DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 42.SAUDI ARABIA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH AFRICA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 44.REST OF LAMEA DIGESTIVE ENZYMES MARKET,2021-2031($MILLION)
  • FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 49.COMPETITIVE DASHBOARD
  • FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 51.ALLERGAN PLC.: NET SALES ,($MILLION)
  • FIGURE 52.ABBVIE INC..: NET SALES ,($MILLION)
  • FIGURE 53.AMWAY CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 54.COUNTRY LIFE LLC..: NET SALES ,($MILLION)
  • FIGURE 55.GARDEN OF LIFE INC..: NET SALES ,($MILLION)
  • FIGURE 56.BIOTICS RESEARCH CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 57.METAGENICS, INC..: NET SALES ,($MILLION)
  • FIGURE 58.ABBOTT NUTRITION..: NET SALES ,($MILLION)
  • FIGURE 59.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
  • FIGURE 60.ARCHER DANIELS MIDLAND COMPANY (DEERLAND ENZYMES).: NET SALES ,($MILLION)
目次
Product Code: A08198

The digestive enzymes market was valued at $699.4 million in 2021, and is projected to reach $1,643.6 million by 2031, registering a CAGR of 8.7% from 2022 to 2031.

Digestive enzymes break down proteins, carbohydrates, and lipids and their supplementation play a role in management of digestive disorders, from lactose intolerance to cystic fibrosis. Several formulations of digestive enzymes are available in the market, being different from each other in terms of enzyme type, source & origin, and dosage. Animals-derived enzymes represent an established standard of care. However, the growing study of plants-based and microbe-derived enzymes offer great advancements of digestive enzyme therapy. Moreover, pancreatic enzyme supplementation is the therapy of choice for management of exocrine pancreatic insufficiency (EPI) in chronic pancreatitis, pancreatic cancer, cystic fibrosis (CF), or diabetes. Required daily dose of enzymes is variable, being related to etiology and severity of clinical features of patients, such as age & body weight and for cystic fibrosis, genotype and intestinal factors affect absorption.

The digestive enzymes market trends like increase in prevalence of digestive problems, increase in unhealthy lifestyle by population, and rise in geriatric population are key factors that fuel growth of the digestive enzyme market. Moreover, surge in number of fitness centers and gymnasiums has also increased demand for dietary supplements, increase in awareness about GI health, and focus on preventive disease management are other factors that contribute toward growth of the market. However, lack of knowledge regarding appropriate dosage amounts and presence of substitutes for digestive enzyme supplements are expected to hinder growth of the market. Conversely, development of customized digestive enzymes offer lucrative opportunities for growth of the market.

The digestive enzymes market is segmented into origin, enzyme type, application, and region. By origin, the market is categorized into animals, microbial, and plants. Further, the animals segment is categorized into prescription medicine, sports nutrition, and infant nutrition. The sports nutrition segment for animals is classified into sports drink and other sport supplements. Further, the microbial segment is categorized into prescription medicine, sports nutrition, and infant nutrition. In addition, the sports nutrition segment for microbial is classified into sports drink and other sport supplements. The plants segment is further categorized into prescription medicine, sports nutrition, and infant nutrition. The sports nutrition for plants is classified into sports drink and other sport supplements. By enzyme type, the market is divided into carbohydrase, protease, lipase, and others. By application, it is divided into prescription medicine, sports nutrition, and infant nutrition. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major companies profiled in the report include Abbott Laboratories, AbbVie Inc., Amway Corporation, Archer Daniels Midland Company, Biotics Research Corporation, Brain Group Co Ltd., Country Life, LLC, Douglas Laboratories, Garden of Life, International Flavors & Fragrances Inc, Johnson & Johnson, Metagenics Inc., Mimi's Rock Corporation, Otsuka Holding Co ltd, Soho Flordis International Health, The Enzymedica Group, Vox Nutrition.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive enzymes market analysis from 2021 to 2031 to identify the prevailing digestive enzymes market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the digestive enzymes market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global digestive enzymes market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Origin

  • Animal
  • Microbial
  • Plant

By Enzyme Type

  • Carbohydrase
  • Protease
  • Lipase
  • Other Enzyme Types

By Applications

  • Prescription Medicine
  • Sports Nutrition
  • Infant Nutrition

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Allergan PLC
    • Abbvie Inc.
    • Amway Corporation
    • Country Life LLC.
    • Garden Of Life Inc.
    • Biotics Research Corporation
    • Metagenics, Inc.
    • Abbott Nutrition.
    • Johnson & Johnson
    • Archer Daniels Midland Company (DeerLand Enzymes)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: DIGESTIVE ENZYMES MARKET, BY ORIGIN

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Animal
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Microbial
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Plant
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: DIGESTIVE ENZYMES MARKET, BY ENZYME TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Carbohydrase
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Protease
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Lipase
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Other Enzyme Types
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: DIGESTIVE ENZYMES MARKET, BY APPLICATIONS

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Prescription Medicine
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Sports Nutrition
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Infant Nutrition
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: DIGESTIVE ENZYMES MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Origin
    • 7.2.3 North America Market size and forecast, by Enzyme Type
    • 7.2.4 North America Market size and forecast, by Applications
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Origin
      • 7.2.5.1.2 Market size and forecast, by Enzyme Type
      • 7.2.5.1.3 Market size and forecast, by Applications
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Origin
      • 7.2.5.2.2 Market size and forecast, by Enzyme Type
      • 7.2.5.2.3 Market size and forecast, by Applications
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Origin
      • 7.2.5.3.2 Market size and forecast, by Enzyme Type
      • 7.2.5.3.3 Market size and forecast, by Applications
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Origin
    • 7.3.3 Europe Market size and forecast, by Enzyme Type
    • 7.3.4 Europe Market size and forecast, by Applications
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Origin
      • 7.3.5.1.2 Market size and forecast, by Enzyme Type
      • 7.3.5.1.3 Market size and forecast, by Applications
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Origin
      • 7.3.5.2.2 Market size and forecast, by Enzyme Type
      • 7.3.5.2.3 Market size and forecast, by Applications
      • 7.3.5.3 U.K.
      • 7.3.5.3.1 Market size and forecast, by Origin
      • 7.3.5.3.2 Market size and forecast, by Enzyme Type
      • 7.3.5.3.3 Market size and forecast, by Applications
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Origin
      • 7.3.5.4.2 Market size and forecast, by Enzyme Type
      • 7.3.5.4.3 Market size and forecast, by Applications
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Origin
      • 7.3.5.5.2 Market size and forecast, by Enzyme Type
      • 7.3.5.5.3 Market size and forecast, by Applications
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Origin
      • 7.3.5.6.2 Market size and forecast, by Enzyme Type
      • 7.3.5.6.3 Market size and forecast, by Applications
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Origin
    • 7.4.3 Asia-Pacific Market size and forecast, by Enzyme Type
    • 7.4.4 Asia-Pacific Market size and forecast, by Applications
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Origin
      • 7.4.5.1.2 Market size and forecast, by Enzyme Type
      • 7.4.5.1.3 Market size and forecast, by Applications
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Origin
      • 7.4.5.2.2 Market size and forecast, by Enzyme Type
      • 7.4.5.2.3 Market size and forecast, by Applications
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Origin
      • 7.4.5.3.2 Market size and forecast, by Enzyme Type
      • 7.4.5.3.3 Market size and forecast, by Applications
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Origin
      • 7.4.5.4.2 Market size and forecast, by Enzyme Type
      • 7.4.5.4.3 Market size and forecast, by Applications
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Origin
      • 7.4.5.5.2 Market size and forecast, by Enzyme Type
      • 7.4.5.5.3 Market size and forecast, by Applications
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Origin
      • 7.4.5.6.2 Market size and forecast, by Enzyme Type
      • 7.4.5.6.3 Market size and forecast, by Applications
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Origin
    • 7.5.3 LAMEA Market size and forecast, by Enzyme Type
    • 7.5.4 LAMEA Market size and forecast, by Applications
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Origin
      • 7.5.5.1.2 Market size and forecast, by Enzyme Type
      • 7.5.5.1.3 Market size and forecast, by Applications
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Origin
      • 7.5.5.2.2 Market size and forecast, by Enzyme Type
      • 7.5.5.2.3 Market size and forecast, by Applications
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Origin
      • 7.5.5.3.2 Market size and forecast, by Enzyme Type
      • 7.5.5.3.3 Market size and forecast, by Applications
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Origin
      • 7.5.5.4.2 Market size and forecast, by Enzyme Type
      • 7.5.5.4.3 Market size and forecast, by Applications

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Allergan PLC
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 Abbvie Inc.
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Amway Corporation
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Country Life LLC.
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Garden Of Life Inc.
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Biotics Research Corporation
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Metagenics, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Abbott Nutrition.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Johnson & Johnson
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Archer Daniels Midland Company (DeerLand Enzymes)
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments